DCAF7 antibody (N-Term)

Catalog No. ABIN928603

This Rabbit Polyclonal antibody specifically detects DCAF7 in WB. It exhibits reactivity toward Human and Mouse.

Quick Overview for DCAF7 antibody (N-Term) (ABIN928603)

Target: DCAF7 (DDB1 and CUL4 Associated Factor 7 (DCAF7))

Reactivity: Human, Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This DCAF7 antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-DCAF7 Antibody

Binding Specificity: N-Term

Cross-Reactivity: Mouse (Murine)

Purification: Purified

Immunogen: Dcaf7 antibody was raised in rabbit using the N terminal of Dcaf7 as the immunogen

Application Details

Application Notes: Optimal conditions should be determined by the investigator.

Comment:

Dcaf7 Blocking Peptide, (ABIN5613131), is also available for use as a blocking control in assays to test for specificity of this Dcaf7 antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Target Details for DCAF7

Target: DCAF7 (DDB1 and CUL4 Associated Factor 7 (DCAF7))

Alternative Name: Dcaf7

Background: Dcaf7 is involved in craniofacial development. It acts upstream of the EDN1 pathway and is required for formation of the upper jaw equivalent, the palatoquadrate. The activity required for EDN1 pathway function differs between the first and second arches. It associates with DIAPH1 and controls GLI1 transcriptional activity. It could be involved in skin development. It may function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex. Synonyms: Polyclonal Dcaf7 antibody, Anti-Dcaf7 antibody, DDB1 and CUL4 associated factor 7 antibody, 1700012F10Rik antibody, 2610037L01Rik antibody, C86529 antibody, HAN11 antibody, Wdr68 antibody.

Pathways: SARS-CoV-2 Protein Interactome